Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;31(4):536-544.
doi: 10.1017/S0963180122000196.

The Evidence for the Pharmaceutical Strengthening of Attachment: What, Precisely, Would Love Drugs Enhance?

Affiliations

The Evidence for the Pharmaceutical Strengthening of Attachment: What, Precisely, Would Love Drugs Enhance?

Peter N Herissone-Kelly. Camb Q Healthc Ethics. 2022 Oct.

Abstract

In recent decades, scientists have begun to identify the brain processes and neurochemicals associated with the different stages of love, including the all-important stage of attachment. Experimental findings-readily seized upon by those bioethicists who want to urge that we sometimes have good reason pharmaceutically to enhance flagging relationships-are presented as demonstrating that attachment is regulated and strengthened by the neuropeptides oxytocin and vasopressin. I shall argue, however, that often what the experimental data in fact show is only that exogenous administration of such chemicals can control and intensify the trappings of attachment, not attachment itself. That this is sometimes overlooked by both scientists and ethicists, is due to attachment being miscategorised as a set of feelings or a drive, rather than as a disposition to think about, feel toward, and behave toward its object in certain distinctive ways.

Keywords: Julian Savulescu; attachment; love drugs; oxytocin; vasopressin.

PubMed Disclaimer

Similar articles

References

    1. Camb Q Healthc Ethics. 2015 Jul;24(3):323-36 - PubMed
    1. Curr Opin Psychiatry. 2013 Sep;26(5):474-484 - PubMed
    1. Trends Neurosci. 1998 Feb;21(2):71-5 - PubMed
    1. Philos Technol. 2012 Dec;25(4):561-587 - PubMed
    1. Philos Psychiatr Psychol. 2017 Mar;24(1):77-92 - PubMed

Substances